Analysis of angiogenesis biomarkers for ramucirumab (RAM) efficacy in patients with metastatic colorectal cancer (mCRC) from RAISE, a global, randomized, double-blind, Phase 3 study
Cited by 3Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis